BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Summary
BrightSpring Health Services reported robust fourth quarter and full year 2025 financial results, significantly exceeding prior year performance. For Q4 2025, net revenue increased 29.3% to $3.551 billion, and net income surged to $49.6 million from $4.3 million in the prior year, while Adjusted EBITDA grew 40.7%. Full year 2025 saw net revenue reach $12.911 billion, up 28.2%, and net income turn positive at $104.8 million compared to a net loss in 2024. The company also provided strong 2026 guidance, projecting revenue growth of 11.9% to 16.2% and Adjusted EBITDA growth of 23.1% to 27.9%. This positive earnings report, coupled with a significant reduction in leverage to 2.99x and strategic operational moves like the Amedisys and LHC acquisition, indicates strong operational momentum and financial health. This news is highly material and likely to have a significant positive impact on the stock, reinforcing its position near 52-week highs. Investors will closely watch the execution of the 2026 guidance and the planned divestiture of the Community Living business.
At the time of this announcement, BTSG was trading at $40.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $15.48 to $41.40. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Unknown.